Research, science & health

Fiona Doetsch is a research group leader at the Biozentrum of the University of Basel. Upon her visit at the Institut du Cerveau - ICM, she presented her work on stem cells, and more specifically, on what triggers their activation. Stem cells could...

The Institut du Cerveau - ICM scientists have recently discovered a mechanism which protects neurons from cell death. The loss of this protective mechanism may contribute to the degeneration of neurons in patients with Parkinson's disease.

The majority of neurodegenerative disorders, from Alzheimer's disease to amyotrophic lateral sclerosis to Parkinson's disease, share common features with prion diseases.

On the occasion of National Epilepsy Day, Vincent Navarro, neurologist and Institut du Cerveau - ICM researcher, and Stéphanie Baulac, co-leader of the team “Genetics and physiology of hereditary epilepsy,” and the start-up Bioserenity led a...

A team at the Institut du Cerveau - ICM showed that different mutations of one gene, ALDH18A1, are associated with several types of hereditary spastic paraplegias and different modes of transmission. Moreover, the researchers identified a new blood...

Karl Friston, Professor of Neuroscience at the University College London, was invited to give a scientific seminar at the Institut du Cerveau - ICM on November 16, 2015. He explains how the understanding of how the brain perceives sensory signals...

The World Stroke Day for cerebral vascular accidents (CVA) took place on October 29, 2015. The research led at the Institut du Cerveau - ICM seeks to better understand these neurological accidents and to improve the recovery and rehabilitation of...

Giovanni Stevanin, researcher at the Brain and Spine Institute (Institut du Cerveau - ICM), and his collaborators identified a recurring mutation in a new gene responsible for cerebellar axatia that en-codes a calcium channel expressed in certain...

Very few people pretend they have never dreamt. Pr. Isabelle Arnulf’s work, Head of sleep disorders at the Pitié-Salpêtrière Hospital and researcher at Paris Brain Institute, and her colleagues, prove that this is false. Everybody dreams, but some do...

Several recent studies confirm that the presence of senile plaques or the beta-amyloid protein permit the diagnosis of Alzheimer disease or predictions as to who will develop the disease.

Why do we like a painting or a person? Does our judgement depend only on the intrinsic value of the painting or the person? What if other factors intervene?

Gait and balance disorders and the associated falls caused by Parkinson disease are a major public health problem.